4-phenylbutyric acid

4-Phenylbutyric acid (Benzenebutyric acid) is a histone deacetylase (HDAC) inhibitor and an endoplasmic reticulum stress (ERS) inhibitor. 4-Phenylbutyric acid can be used to treat urea cycle disorders.

Sodium 4-phenylbutyrate (TriButyrate), a transcriptional regulator, reversibly inhibits class I and II histone deacetylases (HDACs )resulting in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations.

4-Phenylbutyric acid-D11 is the deuterated form of 4-Phenylbutyric acid. 4-Phenylbutyric acid (T5886) (4-PBA) functions as an inhibitor of histone deacetylase (HDAC) and endoplasmic reticulum stress (ERS), making it useful in the study of diseases such as cancer and infections.

4-Phenylbutyric acid-D2 is the deuterated form of 4-Phenylbutyric acid. 4-Phenylbutyric acid (T5886) (4-PBA) acts as an inhibitor of histone deacetylases (HDAC) and endoplasmic reticulum stress (ERS), making it useful for research into diseases such as cancer and infections.

4-Phenylbutyric acid-D5 is a deuterated form of 4-Phenylbutyric acid. 4-Phenylbutyric acid (T5886) (4-PBA) serves as an inhibitor of histone deacetylase (HDAC) and endoplasmic reticulum stress (ERS), and it is utilized in research related to diseases such as cancer and infections.

Phenibut hydrochloride (3-Amino-4-phenylbutyric acid hydrochloride) is a GABA mimetic that acts as an agonist at GABAB receptors, blocks α2δ subunit-containing voltage-gated calcium channels, stimulates dopamine receptors, and inhibits the actions of β-phenethylamine

PEO-IAA (2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid) is a novel potent auxin antagonist.